This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Our objective was to determine whether ICR is associated with a mortality and cardiovascular benefit compared with CR.Methods:Retrospective cohort study of Medicare Fee-For-Service beneficiaries in a 100% sample, claims data set. Moreover, ICR and CR demonstrate a dose-response relationship for mortality.
and $1005 lower subsequent annual Medicare expenditures per beneficiary (95% CI, $1352 to $659). Participants attended 2 sessions of CR within 365 days of the event. Compared with nonparticipants, participants had 47.6 fewer subsequent annual inpatient hospitalizations per 1000 beneficiaries (95% CI, 58.8
Utilization trends were stratified by region, urbanicity, distressed communities index, community versus academic center, Medicare versus dual enrollment status, indication, urgency, and presence of dissection with malperfusion.
Introduction:In recent years, Medicare Advantage (MA) enrollment in the US has increased dramatically relative to traditional Medicare (TM). in 2016 to 32.4% Stroke, Volume 55, Issue Suppl_1 , Page ATP80-ATP80, February 1, 2024. of the 16,231 stroke discharges, respectively. Compared with TM, MA beneficiaries were older (77.4
Introduction:The paucity of large-scale data exploring the effect of prior bariatric surgery on recurrent stroke outcomes in elderly obese stroke survivors led us to address the gap, with an emphasis on the risk of recurrent stroke and its trends.Methods:A retrospective study was conducted using National Inpatient Sample data from 2016-2019.
Methods:Data were retrieved from a CMS Qualified Entity housing healthcare utilization data for ≥80% of the Texas state population (100% of Medicare Fee-for-Service). Analytical sample included all Medicare enrollees with a primary discharge diagnosis (AIS or ICH) from 2016 to 2020.
Methods We conducted a retrospective cohort analysis of individuals with commercial and Medicare Advantage insurance in Optum Labs Data Warehouse who had incident ischaemic or cryptogenic stroke and no prior cardiovascular implantable electronic device from 1 January 2016 to 30 June 2021.
Secondary objectives evaluated all-cause mortality and adverse events following amputation.RESULTS:Of 33 036 total Medicare beneficiaries undergoing major amputation, 7885 (23.9%) were due to chronic limb-threatening ischemia; of these, 4988 (63.3%) received low-intensity and 2897 (36.7%) received high-intensity vascular care.
There are limited population-based data regarding the prevalence of CAA and associated risks of mortality and incident cerebrovascular events.Methods:We performed a retrospective cohort study using inpatient and outpatient claims from 2008 to 2018 from a nationally representative 5% sample of Medicare beneficiaries. 95% CI, 19.6-52.4),
We hypothesize an association between hypoglycemic events and the occurrence of stroke among patients with diabetes.METHODS:We used Medicare inpatient, outpatient, emergency department, and subacute nursing facility data sets from January 1, 2016, to December 31, 2019, and validated usingInternational Classification of Diseases,Tenth Revision, Clinical (..)
Background:Since 2016, hospitals have been able to document International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes for National Institutes of Health Stroke Scale (NIHSS). As of 2023, Center for Medicare & Medicaid Services uses NIHSS as a risk adjustment variable.
The study outcome was a new speech pathology (SLT), occupational therapy (OT), or physical therapy (PT) encounter during the first year after discharge.Results:57,647 total cases were identified with 30% Medicare FFS, 33% Truven (Commercial) Medicare Advantage plan (65 years and older), and 37% Truven commercial (less than 65 years old).
We characterized the vertical integration of the stroke transfer networks using descriptive statistics and the structure using multiple edge directed graphs.Results:We identified 13287, 14217, 15169 stroke transfers in 2016, 2017, and 2018, respectively. In VI stroke transfer networks in 2016, EDs sent stroke transfers to 1.2
We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data. We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data.
Methods:We conducted a national cross-sectional analysis of 71,078,619 adults aged >65 years enrolled in Medicare from January 1, 2016 to December 31, 2019. Among 844,406 Medicare beneficiaries with incident AIS, Black individuals had a 19% increased hazard of AIS compared to White individuals (HR 1.19, 95% CI 1.14-1.25,
Within the PSD cohort, 25 451 (71.5%) had no death or recurrent stroke within 6 months and 5592 (15.7%) had no death or readmission of any cause within 6 months.
We evaluated the influence of early (30-day) post-acute care (PAC) pathways on 1-year HT.Methods:We analyzed a cohort of Medicare AIS patients at a 7-hospital stroke certified health system (2016 to 2020). All claims within 1 year of hospitalization were collated and grouped into corresponding care pathways.
For AIS, we calculated (1) the proportion of White patients at the hospital, (2) the proportional difference in the proportion of White patients between hospital patients and the county, and (3) provider care segregation by the dissimilarity index for ET cases.
Data linkage might offer a solution.Methods:We probabilistically linked data from the Michigan’s Get With The Guidelines Stroke registry and Michigan Value Collaborative multipayer claims database from Medicare and Blue Cross Blue Shield beneficiaries discharged alive following acute stroke (ICD-10 I61-I63) between 2016-2020.
They were more likely insured by Medicare, less by Medicaid, and less likely baseline ambulatory, have a Bachelor’s degree, or own a home, with lower median income.
to identify patients with a diagnosis of AVM from the statewide inpatient and emergency department databases of Florida, Georgia, Maryland, New York, and Washington (2016-2019). Medicare) patients (1.82, 1.45 2.26) had higher odds of receiving surgical AVM treatment (Table 1).
This study evaluated the relationship between community-level distress and CR participation, access to CR facilities, and clinical outcomes.METHODS:A retrospective cohort study was conducted on a 100% sample of Medicare beneficiaries undergoing inpatient coronary revascularization between July 2016 and December 2018.
Medicare, 1.17 [1.08-1.26]; Readmission (RA) to acute care during IR may compromise this favorable recovery trajectory. Across both IR discharge models, patients who were male (aORs: 1.17 [1.08-1.26]; 1.26]; 1.30 [1.18-1.43]), 1.43]), [FV2] had a history of antihypertensive use (1.18 [1.04-1.34]; 1.34]; 1.27 [1.08-1.51]), 2.40]; 2.05 [1.70-2.46])
Patients admitted to IRF or SNF after hospital discharge were confirmed using claims data. Home time was calculated over 90-days and 1-year following hospital discharge by subtracting the number of days spent in inpatient setting (i.e., IRF, SNF, and long-term care) from the number of days alive.
total 1-year home time of <30 days), was evaluated by precision (positive predictive value), recall (sensitivity), and F1 score.Results:Between 2016 and 2020, 75,478 statewide AIS admissions were captured, while 2,889 AIS admissions were analyzed for the matched hospital system subgroup. Cluster models with k = 2 centers (vs.
With growing evidence supporting the role of percutaneous interventions for the treatment of significant TR, understanding these disparities is more crucial than ever.Methods:Data was extracted from the National Readmission 2016 - 2020 Database. and I07.1.
We determined the utility of this score for predicting outcomes within one-year post-stroke/TIA.Methods:Analysis of adults with acute stroke/TIA (2012-2016) using linked data from the Australian Stroke Clinical Registry and administrative datasets (pharmaceutical, hospital, Medicare), as part of the PRECISE study.
3 HeartFlow’s FFR CT Analysis is covered by Medicare and for >99% of commercially insured lives. J Nucl Cardiol 2016. Since its inception, HeartFlow has been committed to building a new standard of care for people at risk of heart disease. For more information: www.heartflow.com References 1. Arbab-Zadeh, Heart Int 2012. Patel et al.
In separate models, we estimated the odds ratio (OR) and 95% confidence intervals (CI) of three outcomes (inpatient mortality, 30-day mortality, and discharge home) using multilevel logistic models for clustered data, with data clustered at the county level.
Between 2016 and 2019, the overall proportion of IRF discharges did not change significantly (21.8% in 2016; 22.1% Medicare) insured (1.73, 1.66-1.79), home and SNF) and report the adjusted odds ratios (aOR) and 95% confidence intervals (CI).Results:Overall, Results:Overall, 335,521 stroke discharges (88.4% Among these, 21.8%
Methods:This retrospective analysis utilized complete, de-identified inpatient Medicare data from January 1, 2016, to December 31, 2019. We included Medicare beneficiaries aged 65 years with incident AIS admissions in large metropolitan and non-urban settings.
However, there are limited population-based data regarding the risk of seizures associated with clinically diagnosed CAA.Methods:We performed a retrospective cohort study using inpatient and outpatient claims from 2016 to 2018 from a nationally representative 5% sample of Medicare beneficiaries.
0.76]) compared with Medicare (HR, 0.85 [95% CI, 0.77–0.92]);Pinteractionsex×insurance The primary outcome was the use of optimal GDMT within 12 months of HFrEF diagnosis. The sex disparities in GDMT use after HFrEF diagnosis were most pronounced among patients with commercial insurance (females compared with males; HR, 0.66 [95% CI, 0.58–0.76])
to -4.8), while CAS use declined from 2006-2016 but increased significantly over 2016-2020 in both men (APC 16.5%, 95%CI 10.0 Stroke, Volume 55, Issue Suppl_1 , Page A49-A49, February 1, 2024. Annual usage of CEA declined from 51.6 cases/100,000 population in both sexes combined (APC -5.4%, 95%CI -6.0 and women (APC 15.2%, 95%CI 10.2
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
40 
Let's personalize your content